Methods and compositions for modulating angiogenesis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 29, 2008
Grant Date -
Apr 11, 2002
app pub date -
Sep 19, 2001
filing date -
Sep 21, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Methods and compositions for modulating angiogenesis in a host are provided. In the subject methods, an effective amount of Ca.sup.2+/calcineurin/NF-ATc signaling pathway modulatory agent is administered to the host. In many embodiments, the Ca.sup.2+/calcineurin/NF-ATc signaling pathway modulatory agent is an NF-ATc antagonist, e.g., in those embodiments of inhibiting angiogenesis. The subject methods find use in a variety of different applications, including the inhibition of tumor growth and the treatment of disease conditions characterized by tumor presence. Also provided are methods of screening for agents that inhibit angiogenesis by modulating the Ca.sup.2+/calcineurin/NF-ATc signaling pathway.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully